Commentary: Impact of Prior Treatment in the Efficacy and Tolerability of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies. | J Clin Aesthet Dermatol;15(10 Suppl 1): S11-S12, 2022 Oct. | MEDLINE

Contenido principal 1 Búsqueda 2 Pie de página 3

+A A -A Alto contraste

Portal Regional de la BVS Paraguay

Información y Conocimiento para la Salud

español

Localizar descriptor de asunto Búsqueda Avanzada

Commentary: Impact of Prior Treatment in the Efficacy and Tolerability of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies.

Schlesinger, Todd.

Afiliación

Schlesinger T; Dr. Schlesinger Affiliate Assistant Professor, Medical University of South Carolina College of Medicine Affiliate Assistant Professor, Medical University of South Carolina College of Health Professions; and Clinical Instructor, Edward Via College of Osteopathic Medicine.

J Clin Aesthet Dermatol ; 15(10 Suppl 1): S11-S12, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36408373

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Clin Aesthet Dermatol Año: 2022 Tipo del documento: Article

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Clin Aesthet Dermatol Año: 2022 Tipo del documento: Article